ST. PAUL, Minn.--(BUSINESS WIRE)--July 17, 2006--MEDTOX Scientific, Inc. (Nasdaq:MTOX - News) announced today results for the second quarter ended June 30, 2006. For the six-month period, revenues increased to $33,749,000, compared to $31,534,000, or 7.0%, from the prior-year period. Operating income increased to $3,875,000 compared to $2,962,000, or 30.8%, from the prior-year period. The Company recorded net income of $2,036,000, or $0.23 per diluted share, compared to net income of $1,436,000, or $0.18 per diluted share, or a 41.8% increase in net income from the comparable period last year.
